Current pipeline of Sass & Sass Inc. consists of two immunomodulatory biologics:

Polyprenyl Immunostimulant whith proven efficacy in clinical testing in feline rhinotracheitis. Recently published data also indicate its potential for treatment of dry form of feline infectious peritonitis. Polyprenyl Immunostimulant is currently undergoing field safety trials; and

SS-07, another immunomodulatory substance which showed a promise in preclinical testing